A detailed history of First Trust Advisors LP transactions in Abb Vie Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 3,076,481 shares of ABBV stock, worth $554 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
3,076,481
Previous 3,194,146 3.68%
Holding current value
$554 Million
Previous $548 Million 10.89%
% of portfolio
0.6%
Previous 0.58%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $19.3 Million - $23.5 Million
-117,665 Reduced 3.68%
3,076,481 $608 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $23.9 Million - $28 Million
-154,686 Reduced 4.62%
3,194,146 $548 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $83.7 Million - $95.4 Million
-523,620 Reduced 13.52%
3,348,832 $610 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $29.4 Million - $33.1 Million
-213,358 Reduced 5.22%
3,872,452 $600 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $50.3 Million - $58.2 Million
-376,411 Reduced 8.44%
4,085,810 $609 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $15.5 Million - $19.3 Million
-117,224 Reduced 2.56%
4,462,221 $601 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $112 Million - $129 Million
777,433 Added 20.45%
4,579,445 $730 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $94.9 Million - $114 Million
686,191 Added 22.02%
3,802,012 $615 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $15.8 Million - $18.2 Million
117,912 Added 3.93%
3,115,821 $418 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $202 Million - $256 Million
1,465,720 Added 95.66%
2,997,909 $459 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $70 Million - $86.8 Million
530,127 Added 52.9%
1,532,189 $248 Million
Q4 2021

Feb 08, 2022

SELL
$107.43 - $135.93 $11.2 Million - $14.2 Million
-104,706 Reduced 9.46%
1,002,062 $136 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $8.59 Million - $9.75 Million
-80,730 Reduced 6.8%
1,106,768 $119 Million
Q2 2021

Oct 12, 2021

SELL
$105.21 - $117.21 $8.59 Million - $9.57 Million
-81,672 Reduced 6.44%
1,187,498 $134 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $18.2 Million - $20.3 Million
-172,909 Reduced 11.99%
1,269,170 $143 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $38.2 Million - $42.1 Million
373,635 Added 34.97%
1,442,079 $156 Million
Q4 2020

Feb 02, 2021

SELL
$80.49 - $108.67 $22.8 Million - $30.7 Million
-282,758 Reduced 20.93%
1,068,444 $114 Million
Q3 2020

Nov 05, 2020

SELL
$85.91 - $100.83 $36.2 Million - $42.5 Million
-421,306 Reduced 23.77%
1,351,202 $118 Million
Q2 2020

Jul 22, 2020

BUY
$73.37 - $98.18 $51.3 Million - $68.7 Million
699,303 Added 65.16%
1,772,508 $174 Million
Q1 2020

May 06, 2020

SELL
$64.5 - $97.79 $432,408 - $655,584
-6,704 Reduced 0.62%
1,073,205 $81.8 Million
Q4 2019

Feb 03, 2020

SELL
$72.13 - $90.25 $8.66 Million - $10.8 Million
-120,045 Reduced 10.0%
1,079,909 $95.6 Million
Q3 2019

Nov 04, 2019

BUY
$62.98 - $75.72 $10 Million - $12 Million
158,805 Added 15.25%
1,199,954 $90.9 Million
Q2 2019

Jul 30, 2019

SELL
$65.7 - $83.98 $21.7 Million - $27.8 Million
-330,828 Reduced 24.11%
1,041,149 $75.7 Million
Q1 2019

May 09, 2019

BUY
$77.14 - $90.79 $51.7 Million - $60.8 Million
670,186 Added 95.5%
1,371,977 $111 Million
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $38.2 Million - $47.1 Million
-490,174 Reduced 41.12%
701,791 $64.7 Million
Q3 2018

Oct 25, 2018

SELL
$88.91 - $98.84 $13.4 Million - $14.8 Million
-150,164 Reduced 11.19%
1,191,965 $113 Million
Q2 2018

Aug 02, 2018

BUY
$89.78 - $106.23 $31.1 Million - $36.8 Million
346,459 Added 34.8%
1,342,129 $124 Million
Q1 2018

Apr 23, 2018

SELL
$92.01 - $123.21 $20 Million - $26.8 Million
-217,183 Reduced 17.91%
995,670 $94.2 Million
Q4 2017

Feb 08, 2018

SELL
$89.56 - $98.21 $7.7 Million - $8.44 Million
-85,957 Reduced 6.62%
1,212,853 $117 Million
Q3 2017

Oct 24, 2017

BUY
$69.85 - $89.22 $90.7 Million - $116 Million
1,298,810
1,298,810 $115 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.